Literature DB >> 3838305

Purification and partial characterization of the b-type cytochrome from human polymorphonuclear leukocytes.

R Lutter, M L van Schaik, R van Zwieten, R Wever, D Roos, M N Hamers.   

Abstract

Polymorphonuclear leukocytes contain an oxidase system that can be activated to produce superoxide radicals and hydrogen peroxide. A nonmitochondrial b cytochrome, functioning in the generation of these oxygen species, has been purified to apparent homogeneity from human polymorphonuclear phagocytes. After solubilization of the cytochrome with Triton X-100, the cell extract was subsequently chromatographed on Blue Sepharose and Sephacryl S-300. The final preparation was maximally purified 170-fold with a specific content of 5.33 +/- 2.03 nmol mg-1 of protein (mean +/- S.D.; n = 7) and a yield of 21 +/- 13% (n = 5). The apparent molecular mass of the nondenatured cytochrome was estimated by gel filtration to be 235 kDa. Upon polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate, a single polypeptide was found with a molecular mass of 127 kDa. From the pyridine hemochrome spectrum 1 protoheme IX/polypeptide was calculated. The light absorbance bands of the dithionite-reduced cytochrome were found to be at 558.5 (alpha), 529 (beta), and 426 nm (Soret), and that of the oxidized cytochrome at 413.5 nm. The difference absorbance coefficients are delta epsilon (426.5 - 440 nm) = 160.6 +/- 11 mM-1 cm-1 and delta epsilon (558.5 - 542 nm) = 29.3 +/- 2 mM-1 cm-1 (mean +/- S.D.; n = 5). Carbon monoxide binds to the cytochrome in a time-dependent fashion (maximum binding after 50-60 min). The midpoint potential of the solubilized nonpurified cytochrome is identical to the cytochrome in situ (Em7.0 = -218 +/- 7 mV (mean +/- S.D.; n = 5)). However, purified cytochrome b shows a significantly decreased midpoint potential, estimated at -407 +/- 18 mV (n = 4). The protein does not contain noncovalently bound FAD or FMN, and no spectral evidence was obtained for the presence of covalently bound flavin. Preliminary amino acid analysis of the cytochrome shows a high content of hydrophilic residues.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3838305

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease.

Authors:  A W Segal
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

2.  Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b.

Authors:  C A Parkos; M C Dinauer; L E Walker; R A Allen; A J Jesaitis; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

3.  Purification of eosinophils from normal human blood, preparation of eosinoplasts and characterization of their functional response to various stimuli.

Authors:  M Yazdanbakhsh; C M Eckmann; M De Boer; D Roos
Journal:  Immunology       Date:  1987-01       Impact factor: 7.397

4.  The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase.

Authors:  A R Cross; O T Jones
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

5.  A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.

Authors:  J H Leusen; M de Boer; B G Bolscher; P M Hilarius; R S Weening; H D Ochs; D Roos; A J Verhoeven
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

6.  Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000.

Authors:  C A Parkos; R A Allen; C G Cochrane; A J Jesaitis
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

7.  Identification of allele-specific p22-phox mutations in a compound heterozygous patient with chronic granulomatous disease by mismatch PCR and restriction enzyme analysis.

Authors:  J P Hossle; M de Boer; R A Seger; D Roos
Journal:  Hum Genet       Date:  1994-04       Impact factor: 4.132

8.  Granulocyte-macrophage colony stimulating factor does not improve neutrophil oxidative metabolism in a patient with variant X-linked chronic granulomatous disease.

Authors:  T J Mühlebach; H J Feickert; K Welte; R A Seger
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

9.  NADPH-binding component of the superoxide-generating oxidase in unstimulated neutrophils and the neutrophils from the patients with chronic granulomatous disease.

Authors:  T Umei; K Takeshige; S Minakami
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

10.  Constitutive NADPH-dependent electron transferase activity of the Nox4 dehydrogenase domain.

Authors:  Yukio Nisimoto; Heather M Jackson; Hisamitsu Ogawa; Tsukasa Kawahara; J David Lambeth
Journal:  Biochemistry       Date:  2010-03-23       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.